Sacituzumab Govitecan for Triple-Negative Breast Cancer.
APA
Xiao L, Lin C (2026). Sacituzumab Govitecan for Triple-Negative Breast Cancer.. The New England journal of medicine, 394(15), 1553. https://doi.org/10.1056/NEJMc2602392
MLA
Xiao L, et al.. "Sacituzumab Govitecan for Triple-Negative Breast Cancer.." The New England journal of medicine, vol. 394, no. 15, 2026, pp. 1553.
PMID
41985148
같은 제1저자의 인용 많은 논문 (5)
- Multi-modal gradual fusion transformer-based model for predicting immunotherapy response in patients with hepatocellular carcinoma.
- The role of mitochondria-endoplasmic reticulum crosstalk in colorectal cancer.
- Current research status of the reverse Warburg effect in cancer-associated fibroblasts of solid tumors.
- Tb-PSMA radioligand therapy in prostate cancer: current evidence and future perspectives.
- Ginsenoside Rb1 carbon nanodots: A green and promising nanomedicine for effective gastric cancer treatment.